Fulcrum Therapeutics Inc (FULC)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -1169.171 | -86.886 | -91.54 | -59.012 | -44.351 | -47.596 | -40.19 |
Return on Equity (%) | 152.539 | 80.77 | -764.851 | -77.681 | -52.717 | -53.533 | -44.841 |
Return on Invested Capital (%) | -3643.899 | -88 | -104.701 | -79.784 | -53.428 | -55.497 | -51.732 |
Operating Margin (%) | N/A | N/A | N/A | -802.663 | -421.891 | -1732.435 | -3470.053 |
Net Profit Margin (%) | N/A | N/A | N/A | -802.663 | -421.891 | -1732.435 | -3470.053 |
Book Value Per Share | 0.194 | 6.837 | 3.847 | 3.406 | 5.207 | 4.896 | 3.804 |
Earnings Per Share | -3.728 | -3.522 | -3.964 | -2.535 | -1.99 | -2.704 | -1.574 |
Cash Per Share | 0.06 | 6.549 | 4.269 | 2.042 | 0.872 | 0.864 | 0.413 |
Working Capital Per Share | -0.213 | 6.285 | 3.882 | 3.321 | 5.09 | 4.695 | 3.696 |
Operating Profit Per Share | N/A | N/A | N/A | 0.316 | 0.472 | 0.156 | 0.045 |
EBIT Per Share | -3.374 | -2.932 | -3.65 | -2.535 | -1.99 | -2.704 | -1.574 |
EBITDA Per Share | -3.374 | -2.932 | -3.65 | -2.535 | -1.99 | -2.704 | -1.574 |
Free Cash Flow Per Share | -3.552 | -2.835 | -4.013 | -2.572 | -2.01 | -2.715 | -1.601 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 6,81M | 11,12M | 22,65M | 27,94M | 40,63M | 40,64M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | 52,05M | 40,64M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -8399.661 | -4132.936 | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | -8399.661 | -4132.936 | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 263,76M |
Ratio cours/bénéfice | -2,48 |
Ratio prix/ventes | 86,15 |
Ratio prix/liquidités | 9,45 |
Ratio prix/valeur comptable | 1,03 |
Rendement de dividende | - |
Actions en circulation | 53,94M |
Volume moyen (1 semaine) | 554,92k |
Volume moyen (1 mois) | 1,15M |
Variation sur 52 semaines | -40,03% |
Plus haut sur 52 semaines | 13,70 |
Plus bas sur 52 semaines | 2,86 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales